Chinese Journal of Antituberculosis ›› 2023, Vol. 45 ›› Issue (12): 1125-1130.doi: 10.19982/j.issn.1000-6621.20230353
• Special Topic • Previous Articles Next Articles
Received:
2023-10-07
Online:
2023-12-10
Published:
2023-11-27
Contact:
Lu Shuihua, Email: Supported by:
CLC Number:
Wang Jin, Lu Shuihua. Discipline construction of tuberculosis: from clinical resources to medical research-based translational medicine[J]. Chinese Journal of Antituberculosis, 2023, 45(12): 1125-1130. doi: 10.19982/j.issn.1000-6621.20230353
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20230353
[1] | World Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization, 2022. |
[2] | 卢水华. 关注结核病共患病已成为公共卫生的需要. 结核与肺部疾病杂志, 2022, 3(4): 255-260. doi:10.19983/j.issn.2096-8493.20220107. |
[3] | Lange C, Aaby P, Behr MA, et al. 100 years of Mycobacterium bovis bacille Calmette-Guérin. Lancet Infect Dis, 2022, 22(1): e2-e12. doi:10.1016/S1473-3099(21)00403-5. |
[4] |
Abubakar I, Pimpin L, Ariti C, et al. Systematic review and meta-analysis of the current evidence on the duration of protection by bacille Calmette-Guérin vaccination against tuberculosis. Health Technol Assess, 2013, 17(37): 1-372, v-vi. doi:10.3310/hta17370.
pmid: 24021245 |
[5] |
Nguipdop-Djomo P, Heldal E, Rodrigues LC, et al. Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study. Lancet Infect Dis, 2016, 16(2): 219-226. doi:10.1016/S1473-3099(15)00400-4.
pmid: 26603173 |
[6] | National Research Council US Committee on A Framework for Developing a New Taxonomy of Disease. Toward Precision Medicine:Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. Washington (DC): National Academies Press (US), 2011. |
[7] | Turnbull C, Scott RH, Thomas E, et al. The 100000 Genomes Project: bringing whole genome sequencing to the NHS. BMJ, 2018, 361: k1687. doi:10.1136/bmj.k1687. |
[8] | All of Us Research Program Investigators, Denny JC, Rutter JL, et al. The “All of Us” Research Program. N Engl J Med, 2019, 381(7): 668-676. doi:10.1056/NEJMsr1809937. |
[9] | Kaiser J. NIH’s ‘precision nutrition’ bet aims for individualized diets. Science, 2021, 371(6529): 552. doi:10.1126/science.371.6529.552. |
[10] |
Denny JC, Collins FS. Precision medicine in 2030-seven ways to transform healthcare. Cell, 2021, 184(6): 1415-1419. doi:10.1016/j.cell.2021.01.015.
pmid: 33740447 |
[11] | CRyPTIC Consortium and the 100,000 Genomes Project, Allix-Béguec C, Arandjelovic I, et al. Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing. N Engl J Med, 2018, 379(15):1403-1415. doi:10.1056/NEJMoa1800474. |
[12] | The CRyPTIC Consortium. A data compendium associating the genomes of 12,289 Mycobacterium tuberculosis isolates with quantitative resistance phenotypes to 13 antibiotics. PLoS Biol, 2022, 20(8): e3001721. doi:10.1371/journal.pbio.3001721. |
[13] | Huang H, Wang C, Rubelt F, et al. Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening. Nat Biotechnol, 2020, 38(10): 1194-1202. doi:10.1038/s41587-020-0505-4. |
[14] | Chen JX, Han YS, Zhang SQ, et al. Novel therapeutic evaluation biomarkers of lipid metabolism targets in uncomplicated pulmonary tuberculosis patients. Signal Transduct Target Ther, 2021, 6(1): 22. doi:10.1038/s41392-020-00427-w. |
[15] |
Cliff JM, Lee JS, Constantinou N, et al. Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J Infect Dis, 2013, 207(1): 18-29. doi:10.1093/infdis/jis499.
pmid: 22872737 |
[16] | DiNardo AR, Gandhi T, Heyckendorf J, et al. Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes. Eur Respir J, 2022, 60(3): 2102263. doi:10.1183/13993003.02263-2021. |
[17] | Heyckendorf J, Marwitz S, Reimann M, et al. Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model. Eur Respir J, 2021, 58(3): 2003492. doi:10.1183/13993003.03492-2020. |
[18] | Mulenga H, Musvosvi M, Mendelsohn SC, et al. Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis. Am J Respir Crit Care Med, 2021, 204(12): 1463-1472. doi:10.1164/rccm.202103-0548OC. |
[19] |
Turner CT, Gupta RK, Tsaliki E, et al. Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: a prospective, observational, diagnostic accuracy study. Lancet Respir Med, 2020, 8(4): 407-419. doi:10.1016/S2213-2600(19)30469-2.
pmid: 32178775 |
[20] | van Doorn CLR, Eckold C, Ronacher K, et al. Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment. EBioMedicine, 2022, 82:104173. doi:10.1016/j.ebiom.2022.104173. |
[21] |
Scriba TJ, Fiore-Gartland A, Penn-Nicholson A, et al. Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial. Lancet Infect Dis, 2021, 21(3): 354-365. doi:10.1016/S1473-3099(20)30914-2.
pmid: 33508224 |
[22] | Marakalala MJ, Raju RM, Sharma K, et al. Inflammatory signaling in human tuberculosis granulomas is spatially orga-nized. Nat Med, 2016, 22(5):531-538. doi:10.1038/nm.4073. |
[23] |
Huang Z, LaCourse SM, Kay AW, et al. CRISPR detection of circulating cell-free Mycobacterium tuberculosis DNA in adults and children, including children with HIV: a molecular diagnostics study. Lancet Microbe, 2022, 3(7): e482-e492. doi:10.1016/S2666-5247(22)00087-8.
pmid: 35659882 |
[24] |
Wallis RS, Ginindza S, Beattie T, et al. Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial. Lancet Respir Med, 2021, 9(8): 897-908. doi:10.1016/S2213-2600(20)30448-3.
pmid: 33740465 |
[25] | Marks GB, Nguyen NV, Nguyen PTB, et al. Community-wide Screening for Tuberculosis in a High-Prevalence Setting. N Engl J Med, 2019, 381(14): 1347-1357. doi:10.1056/NEJMoa1902129. |
[26] | 中国防痨协会. 高危人群结核分枝杆菌潜伏感染检测及预防性治疗专家共识. 中国防痨杂志, 2021, 43(9):874-878. doi:10.3969/j.issn.1000-6621.2021.09.004. |
[1] | Zhao Yanli, Che Nanying. Interpretation of social organization standard of Specification for Pathological Diagnosis of Tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 371-374. |
[2] | Xu Chenyi, Chen Hui, Zhong Jiyuan, Ding Xiaoyan, Yang Rui, Xu Xiangchao, Zhang Canyou, Cheng Jun, Li Tao. Investigation on the status of tuberculosis infection among household student close contacts of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 375-382. |
[3] | Chen Ruiqi, Zhang Mingwu, Wang Wei, Chen Songhua, Liu Zhengwei, Chen Bin. Prevalence and influencing factors of latent tuberculosis infection among elderly rural residents in Changshan County, Zhejiang Province [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 383-389. |
[4] | Fan Xiaolei, Maiwulajiang·Yimamu , Peng Xiaowang, Hu Pengyuan, Wang Yanjie, Alimire·Abulimiti , Mairihaba·Kamili , Wang Senlu, Xiang Yang. Analysis of the incidence and influencing factors of household close contacts of pulmonary tuberculosis patients in Kashgar, Xinjiang Uygur Autonomous Region, 2018—2021 [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 390-396. |
[5] | Teng Chong, Wang Yulan, Liu Liu, Zhang Fang, Huang Fei, Li Tao, Zhao Bing, Zhao Yanlin, Ou Xichao. Analysis of the epidemiological characteristics and prediction for the reported incidence of pulmonary tuberculosis in Dongcheng District, Beijing from 2013 to 2022 [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 397-402. |
[6] | Yang Chao, Wang Jing, Yang Chaohui, Gao Hanqing. Analysis of the epidemiological characteristics and treatment outcomes of pulmonary tuberculosis aged ≥60 years old in Tongzhou District of Beijing, 2016—2022 [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 403-410. |
[7] | Li Xueqiu, Kuang Haobin, Wang Ting, Min Fei, Tao Lan, Cao Xihui, Li Xiang, Liu Guobiao. Analysis of self-paid medical expenses and influencing factors for multidrug-resistant tuberculosis patients in Guangzhou City [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 411-417. |
[8] | Wang Liyan, Zhou Hui, Wu Qian, Hao Xiaogang, Lu Bingxin, Chen Bin. Evaluation of the implementation effect of the “Zero Burden” strategy for diagnosis and treatment of pulmonary tuberculosis in Longyou County, Zhejiang Province [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 418-423. |
[9] | Zhou Shuang, Zong Di, Li Shixue, Du Jian. Analysis of influencing factors of tuberculosis patients’ medical experience with the internet hospital platform [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 424-432. |
[10] | Ni Shuaihu, Wang Jia, Chen Gang, Dong Longyu, Wang Ni, Luo Xiaofeng, Qu Yan, ZhaoYanlin . Analysis of the influence of receiving health education on knowledge, belief and behavior of college students in four provinces in China [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 433-439. |
[11] | Li Yang, Chen Bin, Peng Ying, Chen Xinyi, Jiang Jianmin. Investigation and analysis of social discrimination and awareness of pulmonary tuberculosis among junior college students in Zhejiang Province [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 440-448. |
[12] | Shang Xuetian, Dong Jing, Huang Mailing, Sun Qi, Jia Hongyan, Zhang Lanyue, Liu Qiuyue, Yao Mingxu, Wang Yingchao, Ji Xiuxiu, Du Boping, Xing Aiying, Pan Liping. Transcriptome study on peripheral blood mononuclear cells of latent tuberculosis infection individuals [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 449-460. |
[13] | Zheng Hailun, Li Yamin, Sun Shanhua, He Xiaoxin. Analysis of influencing factors on treatment interruption in 317 pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 467-472. |
[14] | Wen Shufang, Wei Rongrong, Li Haoran, Liu Yi. The role of CD4+ and CD8+T cells in the immune response to tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 479-484. |
[15] | Pei Shaojun, Ou Xichao. Interpretation of the World Health Organization’s Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance (2nd Edition) [J]. Chinese Journal of Antituberculosis, 2024, 46(3): 260-266. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||